GSK

Earlier this year, Sandra Gallina, the Italian bureaucrat in charge of buying coronavirus vaccines for the EU, appeared in front of the European parli(...)

The northern hemisphere faces a bleak winter of rising Covid-19 cases, but signals that two rapidly engineered vaccines by Pfizer and Moderna work on (...)

Pharma group GlaxoSmithKline cautioned full-year earnings would likely come in at the lower end of its forecast range after the Covid-19 pandemic took(...)

French drugmaker Sanofi and Britain’s GlaxoSmithKline will supply 200 million doses of their Covid-19 candidate vaccine to a global inoculation scheme(...)

The race for a coronavirus vaccine has stoked a debate on how much the jabs will cost and who will pay for them, as prices range from $3 to more than (...)

European shares fell for a third straight session on Wednesday, as losses in healthcare and construction stocks countered a lift from encouraging earn(...)

AstraZeneca started late-stage trials for an antibody medicine against Covid-19 with a large investment from the US, after President Donald Trump cred(...)

A new cocktail of enzymes that speeds up the degradation of plastic offers a step forward in finding a new form of recycling that is faster, more affo(...)

AstraZeneca has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a st(...)

Nine leading US and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held ag(...)